Abstracts tagged "clinical practice guidelines and oral"

Abstract Number: 624 • 2015 ACR/ARHP Annual Meeting
Sjögren’s Syndrome Foundation Clinical Practice Guidelines for Oral Disease Management: Caries Prevention
Frederick B Vivino¹, Domenick Zero², Michael Brennan³, Troy Daniels⁴, Carol Stewart⁵, Athena Papas⁶, Andres Pinto⁷, James Sciubba⁸, Ibtisam Al-Hashimi⁹, Mahvash Navazesh¹⁰, Nelson L. Rhodus¹¹, Mabi Singh¹², Ava Wu¹³, Philip Fox¹⁴, Stephen Cohen¹⁵, Theresa Lawrence Ford¹⁶, Sharon Tracy¹⁷, Julie Frantsve-Hawley¹⁷, Katherine M. Hammitt¹⁴ and Sjogren's Syndrome Foundation Clinical Practice Guidelines Committee, ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Indiana University School of Dentistry, Indianapolis, IN, ³Carolinas Medical Center, Charlotte, NC, ⁴Orofacial Sciences, UCSF School of Medicine & Dentistry, San Francisco, CA, ⁵University of Florida College of Dentistry, Gainesville, FL, ⁶Oral Medicine, Tufts University, Boston, MA, ⁷Case Western Reserve University, Cleveland, OH, ⁸The John Hopkins School of Medicine, Baltimore, MD, ⁹Baylor College of Dentistry, Dallas, TX, ¹⁰University of Southern California, Los Angeles, CA, ¹¹Department of Oral Surgery, University of Minnesota School of Dentistry, Minneapolis, MN, ¹²Tufts University School of Dental Medicine, Boston, MA, ¹³University of California School of Dentistry, San Francisco, CA, ¹⁴Sjögren's Syndrome Foundation, Bethesda, MD, ¹⁵Dr. Stephen Cohen-Doctor My Eyes, Scottsdale, AZ, ¹⁶North Georgia Rheumatology Group, PC, Lawrenceville, GA, ¹⁷American Dental Association, Chicago, IL
Background/Purpose: Salivary dysfunction in Sjögren’s (SS) can lead to serious and costly oral complications including accelerated caries and, in some cases, loss of dentition. Clinical…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].